Monthly Archives: October 2010

GMP Stem cells

A recent press release by the California Institute of Regenerative Medicine announced the award of $6 million to the lab of Xianmin Zeng, Ph.D., of the Buck Institute for Age Research and The City of Hope, a small biotech research/treatment center in Californina, to generate human stem cells that may one day be suitable for clinical treatment in Parkinson’s. What Dr. Zeng’s lab has accomplished – and now has funding to try on a large scale – is the ability to grow and differentiate stems cells using defined culture conditions – an important aspect of Good Manufacturing Practice (GMP) that… read more Read More

WPC: Final Thoughts

As the 2nd World Parkinson Congress comes to a close, PDF is humbled and honored to include the following closing thoughts from guest blogger and CRLI/WPC reporter, Diane G. Cook.World Parkinson Congress: A “Tremor Safe” Zone “Here at the World Parkinson Congress, we’re in a Tremor Safe Zone.” Those words were spoken by Davis Phinney to describe how it feels to be among thousands of others where it’s okay to have PD. No one notices the drag of foot, the slowness of step, the shakiness of hand, the softness of voice. Everyone does it! No self consciousness here! But there’s… read more Read More

WPC Posters: More CRLI Grads Present

As we chatted about in a previous post, the 2nd World Parkinson Congress includes two poster sessions, one led by researchers about the science and care of Parkinson’s and another led by Parkinson’s community members who have made efforts in their community to move the cause forward. We profiled a few of PDF’s CRLI graduates yesterday and wanted to update you on some other individuals who have presented their work. Check out Israel’s poster on the left and a list of others who presented during the week. Israel RobledoParkinson’s Outreach. Hope For Tomorrow. Help For Today (Robledo, I)Israel works to… read more Read More

WPC Roving Reporters: Day Three Science

The 2nd World Parkinson Congress continues its three days of sessions discussing the latest news in Parkinson’s science and care. PDF’s reporters have been listening in to a variety of these sessions. We’ve asked them to report back on what they have seen and heard, sharing the messages that mean the most to them as people living with Parkinson’s. Jackie Hunt ChristensenAttended: Non-Drug Approaches to Treatments for Parkinson’s Disease “This session covered how some symptoms of Parkinson’s disease might be improved by exercise; physical therapy; speech therapy; and non-drug, cognitive and psychological therapies. Exercise: It was reported that exercise can… read more Read More

WPC Roving Reporters: Day Two Science

The 2nd World Parkinson Congress continues its three days of sessions discussing the latest news in Parkinson’s science and care. PDF’s reporters have been listening in to a variety of these sessions. They are reporting back what they have seen and heard….and sharing the most important messages they are hearing as people living with Parkinson’s. Please note that this post was updated on October 5. Kate Kelsall Attended: Music as Pleasure and How It Can Empower YouPresenter: Concetta (Connie) Tomaino, D.A., MT-BC, LCAT, Executive Director of the Institute for Music and Neurologic Function in the Bronx, New York “Some of… read more Read More

WPC Science Day Two: Genetics Updates

From James Beck, Ph.D., Director of Research Programs Here are some additional scientific updates from this week’s 2nd World Parkinson Congress (WPC). Michael Schlossmacher, M.D., reported the results of his recent experiments that demonstrate that mutations in the GBA gene, which were recently identified as a major risk factor for Parkinson’s disease (PD), actually contribute to an increase in the levels of alpha-synuclein in nerve cells. Alpha-synuclein is the protein that accumulates in dying nerve cells and is the hallmark of Parkinson’s disease. This result provides a biological explanation as to the significance of these GBA mutations and their relevance… read more Read More